This combination treatment successfully induces pro-apoptotic mechanism not only in HCC cells having wild-type p53 but also in p53 mutated cells, which appears to be a significant hurdle for beneficial treatment. The gene discussed is TP53; the disease is hepatocellular carcinoma.